Shaheen Kavoussi, Abbvie, Inc. (C), Abbvie, Inc. (R);
Joseph Nezgoda, Abbvie, Inc. (C), Genentech (C), Genentech (R), Novartis (C), Novartis (R);
Jay Chhablani, Abbvie, Inc. (C), Biogen (C);
Daniel Kiernan, Abbvie, Inc. (F), Abbvie, Inc. (C), Abbvie, Inc. (R), Regeneron (C), Regeneron (R);
Seenu Hariprasad, Abbvie, Inc. (C), Alimera Sciences (C), Bausch & Lomb (C), Biogen (C), Clearside Biomedical (C), EyePoint Pharmaceuticals (C), Regeneron (C), Spark Therapeutics (C);
Sonny Caplash, None;
Joseph Martel, None;
Michael Singer, Abbvie, Inc. (C), Abbvie, Inc. (R), Abbvie, Inc. (F), Aerie Pharmaceuticals (C), Aerie Pharmaceuticals (F), Allegro (C), Allegro (F), Eyepoint (C), Genentech (R), Genentech (C), Genentech (F), Icon (F), Ionis (F), Kalvista (F), Kodiak (C), Kodiak (F), Mallinckrodt (R), Novartis (C), Novartis (R), Novartis (F), Opthea (F), Optos (F), Regeneron (C), Santen (C), Spark Therapeutics (R)